MedPath
EMA Product

Viagra

Product approved by European Medicines Agency (EU)

Basic Information

Viagra

Regulatory Information

EMEA/H/C/000202

Authorised

September 13, 1998

May 27, 1998

50

September 5, 2024

Company Information

Netherlands

Rivium Westlaan 142 Capelle aan den Ijssel 2909 LD

Upjohn EESV

Active Ingredients

Active Substances Detail

Detailed Information

Therapeutic Indication

### Therapeutic indication Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Viagra to be effective, sexual stimulation is required.

Overview Summary

This is a summary of the European public assessment report (EPAR) for Viagra. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Viagra.

© Copyright 2025. All Rights Reserved by MedPath